TCTAP A-142 Monitoring and Titration of Conventional and Newer Antiplatelet Therapies in Post PCI Patients Using Platelet Function Assay: A Tertiary Care Hospital Experience from Eastern India

Current guideline-based antiplatelet therapies promote a “one size fits all” concept despite multiple clinical studies consistently reporting heterogeneity of patient response to antiplatelet therapy. Conclusion Mandatory dual antiplatelet therapy remains the cornerstone of maintenance therapy in Post PCI patients. Despite the advent of newer more potent antiplatelet agents a significant population of Post PCI patients still continues on Clopidogrel and aspirin, predominantly due to economic constraints. Despite the heterogeneity of response to clopidogrel compared to...